Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in youngsters and individuals. In Canada, its access is strictly regulated by Health https://sandozlisdexamfetaminein936411.seowebsiteblog.com/61733623/this-medication-in-canada-a-comprehensive-guide